Rev.1 Engineering, a premier medical device development and manufacturing firm, is pleased to announce that Michael Grossman, Director of Sales, will represent the company at the upcoming Tokyo Biodesign Healthtech Innovation Day 2026.
The event serves as a critical junction for global healthcare leaders, academic innovators, and industry pioneers to discuss the future of medical technology and overseas expansion.
Supporting the Future of Healthtech Innovation
As a specialist in medical device development and manufacturing, Rev.1 Engineering partners with innovators to navigate the early and mid-stages of product development—from initial concept and prototyping to low-volume manufacturing. By attending, Michael aims to support Japanese MedTech teams in bridging the gap between local innovation and international commercialization, ensuring their functional devices are prepared for the complexities of downstream global scale.
About Rev.1 Engineering
Rev.1 Engineering is a medical device development and manufacturing company that partners with startups and OEMs to support the early and mid-stages of product development. From concept development and prototyping to low-volume manufacturing, Rev.1 helps MedTech teams turn ideas into functional, manufacturable devices while preparing for downstream scale and commercialization.
